Diovan

DRUG2 trials

Sponsors

Bayer, Baylor Research Institute

Conditions

Chronic Kidney DiseaseHypertensionType 2 Diabetes

Phase 4

Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

CompletedNCT01518855

BayerHypertension

Start: 2004-03-31End: 2005-04-30Updated: 2012-01-26

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Not yet recruitingNCT07547878

Baylor Research InstituteChronic Kidney Disease, Type 2 Diabetes

Start: 2026-04-30End: 2029-03-31Target: 64Updated: 2026-05-08